$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

A Redox-Sensitive Micelle-Like Nanoparticle Self-Assembled from Amphiphilic Adriamycin-Human Serum Albumin Conjugates for Tumor Targeted Therapy 원문보기

BioMed research international, v.2015, 2015년, pp.987404 -   

Chen, Lin (Department of Medical Oncology, East Hospital, Tongji University, 150 Jimo Road, Shanghai 200120, China) ,  Chen, Feng (Department of Cardiology, Changhai Hospital, The Second Military Medical University, Shanghai 200433, China) ,  Zhao, Mengxin (International Joint Cancer Institute, The Second Military Medical University, Shanghai 200433, China) ,  Zhu, Xiandi (International Joint Cancer Institute, The Second Military Medical University, Shanghai 200433, China) ,  Ke, Changhong (International Joint Cancer Institute, The Second Military Medical University, Shanghai 200433, China) ,  Yu, Jiangming (Department of Orthopaedics, Changzheng Hospital, The Second Military Medical University, No. 415 Fengyang Road, Shanghai 200003, China) ,  Yan, Zhiqiang (Institute of Biomedical Engineering and Technology, Shanghai Engineering Research Center of Molecular Therapeutics, Shanghai 200062, China) ,  Zhang, Fulei (International Joint Cancer Institute, The Second Military Medical University, Shanghai 200433, China) ,  Sun, Yun (International Joint Cancer Institute, The Second Military Medical University, Shanghai 200433,) ,  Chen, Di ,  Jiang, Cheng ,  Zhao, Xianxian ,  Gao, Yong ,  Guo, Shangjing ,  Li, Wei

Abstract AI-Helper 아이콘AI-Helper

The application of chemotherapeutic drug adriamycin (ADR) in cancer therapy is limited by its side effects like high toxicity and insolubility. Nanomedicine offers new hope for overcoming the shortcomings. But how to increase in vivo stability and to control intracellular drug release is a key issue...

참고문헌 (35)

  1. 1 Myers C. E. McGuire W. P. Liss R. H. Ifrim I. Grotzinger K. Young R. C. Adriamycin: the role of lipid peroxidation in cardiac toxicity and tumor response Science 1977 197 4299 165 167 10.1126/science.877547 2-s2.0-0017656527 877547 

  2. 2 Li W. Li J. Gao J. The fine-tuning of thermosensitive and degradable polymer micelles for enhancing intracellular uptake and drug release in tumors Biomaterials 2011 32 15 3832 3844 10.1016/j.biomaterials.2011.01.075 2-s2.0-79952750426 21377724 

  3. 3 Joshi G. Sultana R. Tangpong J. Free radical mediated oxidative stress and toxic side effects in brain induced by the anti cancer drug adriamycin: insight into chemobrain Free Radical Research 2005 39 11 1147 1154 10.1080/10715760500143478 2-s2.0-27744462197 16298740 

  4. 4 Yen H.-C. Oberley T. D. Vichitbandha S. Ho Y.-S. St. Clair D. K. The protective role of manganese superoxide dismutase against adriamycin-induced acute cardiac toxicity in transgenic mice The Journal of Clinical Investigation 1996 98 5 1253 1260 10.1172/jci118909 2-s2.0-0029781555 8787689 

  5. 5 Janes K. A. Fresneau M. P. Marazuela A. Fabra A. Alonso M. J. Chitosan nanoparticles as delivery systems for doxorubicin Journal of Controlled Release 2001 73 2-3 255 267 10.1016/S0168-3659(01)00294-2 2-s2.0-0035850215 11516503 

  6. 6 Du J.-Z. Du X.-J. Mao C.-Q. Wang J. Tailor-Made dual pH-sensitive polymer-doxorubicin nanoparticles for efficient anticancer drug delivery Journal of the American Chemical Society 2011 133 44 17560 17563 10.1021/ja207150n 2-s2.0-80455168058 21985458 

  7. 7 Dreis S. Rothweiler F. Michaelis M. Cinatl J. Jr. Kreuter J. Langer K. Preparation, characterisation and maintenance of drug efficacy of doxorubicin-loaded human serum albumin (HSA) nanoparticles International Journal of Pharmaceutics 2007 341 1-2 207 214 10.1016/j.ijpharm.2007.03.036 2-s2.0-34447623755 17478065 

  8. 8 Langer K. Balthasar S. Vogel V. Dinauer N. von Briesen H. Schubert D. Optimization of the preparation process for human serum albumin (HSA) nanoparticles International Journal of Pharmaceutics 2003 257 1-2 169 180 10.1016/s0378-5173(03)00134-0 2-s2.0-0037433794 12711172 

  9. 9 Hawkins M. J. Soon-Shiong P. Desai N. Protein nanoparticles as drug carriers in clinical medicine Advanced Drug Delivery Reviews 2008 60 8 876 885 10.1016/j.addr.2007.08.044 2-s2.0-42649132499 18423779 

  10. 10 Li W. Feng S. Guo Y. Tailoring polymeric micelles to optimize delivery to solid tumors Nanomedicine 2012 7 8 1235 1252 10.2217/nnm.12.88 2-s2.0-84868098778 22931449 

  11. 11 Cecco S. Aliberti M. Baldo P. Giacomin E. Leone R. Safety and efficacy evaluation of albumin-bound paclitaxel Expert Opinion on Drug Safety 2014 13 4 511 520 10.1517/14740338.2014.893293 2-s2.0-84899100191 24559090 

  12. 12 Kratz F. Albumin as a drug carrier: design of prodrugs, drug conjugates and nanoparticles Journal of Controlled Release 2008 132 3 171 183 10.1016/j.jconrel.2008.05.010 2-s2.0-56949084877 18582981 

  13. 13 Wosikowski K. Biedermann E. Rattel B. In vitro and in vivo antitumor activity of methotrexate conjugated to human serum albumin in human cancer cells Clinical Cancer Research 2003 9 5 1917 1926 2-s2.0-0038327602 12738750 

  14. 14 Osadnik K. M. Jelonek K. The influence of conjugates on their functionality in the therapy of solid tumors Acta Poloniae Pharmaceutica 2013 70 3 379 386 2-s2.0-84878072167 23757927 

  15. 15 Li W. Wei H.-F. Li H. Gao J. Feng S.-S. Guo Y.-J. Cancer nanoimmunotherapy using advanced pharmaceutical nanotechnology Nanomedicine 2014 9 16 2587 2606 10.2217/nnm.14.127 25490427 

  16. 16 Lehner R. Wang X. Wolf M. Hunziker P. Designing switchable nanosystems for medical application Journal of Controlled Release 2012 161 2 307 316 10.1016/j.jconrel.2012.04.040 2-s2.0-84862661182 22580190 

  17. 17 Kuppusamy P. Li H. Ilangovan G. Noninvasive imaging of tumor redox status and its modification by tissue glutathione levels Cancer Research 2002 62 1 307 312 2-s2.0-0036144680 11782393 

  18. 18 Meng F. H. Hennink W. E. Zhong Z. Y. Reduction-sensitive polymers and bioconjugates for biomedical applications Biomaterials 2009 30 12 2180 2198 10.1016/j.biomaterials.2009.01.026 2-s2.0-60849122214 19200596 

  19. 19 Kuppusamy P. Afeworki M. Shankar R. A. In vivo electron paramagnetic resonance imaging of tumor heterogeneity and oxygenation in a murine model Cancer Research 1998 58 7 1562 1568 2-s2.0-0032054824 9537265 

  20. 20 Cui C. Xue Y.-N. Wu M. Cellular uptake, intracellular trafficking, and antitumor efficacy of doxorubicin-loaded reduction-sensitive micelles Biomaterials 2013 34 15 3858 3869 10.1016/j.biomaterials.2013.01.101 2-s2.0-84874964610 23452389 

  21. 21 He H. Kuang H. Yan L. A reduction-sensitive carrier system using mesoporous silica nanospheres with biodegradable polyester as caps Physical Chemistry Chemical Physics 2013 15 34 14210 14218 10.1039/c3cp51947c 2-s2.0-84881430875 23880907 

  22. 22 Russo A. DeGraff W. Friedman N. Mitchell J. B. Selective modulation of glutathione levels in human normal versus tumor cells and subsequent differential responses to chemotherapy drugs Cancer Research 1986 46 6 2845 2848 2-s2.0-0022537052 2421885 

  23. 23 Bauhuber S. Hozsa C. Breunig M. Göpferich A. Delivery of nucleic acids via disulfide-based carrier systems Advanced Materials 2009 21 32-33 3286 3306 10.1002/adma.200802453 2-s2.0-70249098887 20882498 

  24. 24 Lv L. P. Xu J. P. Liu X. S. Liu G. Y. Yang X. Ji J. Disulfide-crosslinked biomimetic micelles: formation, thiol reactivity and cytotoxicity behavior Macromolecular Chemistry and Physics 2010 211 21 2292 2300 10.1002/macp.201000458 2-s2.0-78249279396 

  25. 25 Sun H. Meng F. Cheng R. Deng C. Zhong Z. Reduction-sensitive degradable micellar nanoparticles as smart and intuitive delivery systems for cancer chemotherapy Expert Opinion on Drug Delivery 2013 10 8 1109 1122 10.1517/17425247.2013.783009 2-s2.0-84880537776 23517599 

  26. 26 Cui C. Xue Y.-N. Wu M. Poly(L-aspartamide)-based reduction-sensitive micelles as nanocarriers to improve doxorubicin content in cell nuclei and to enhance antitumor activity Macromolecular Bioscience 2013 13 8 1036 1047 10.1002/mabi.201300031 2-s2.0-84882588393 23828842 

  27. 27 Gao Y. Chen L. Zhang Z. Chen Y. Li Y. Reversal of multidrug resistance by reduction-sensitive linear cationic click polymer/iMDR1-pDNA complex nanoparticles Biomaterials 2011 32 6 1738 1747 10.1016/j.biomaterials.2010.11.001 2-s2.0-78650302426 21112086 

  28. 28 Cheng G. He Y. Xie L. Development of a reduction-sensitive diselenide-conjugated oligoethylenimine nano particulate system as a gene carrier International Journal of Nanomedicine 2012 7 3991 4006 10.2147/ijn.s32961 2-s2.0-84870349130 22904624 

  29. 29 Zhang L. Xue H. Cao Z. Keefe A. Wang J. Jiang S. Multifunctional and degradable zwitterionic nanogels for targeted delivery, enhanced MR imaging, reduction-sensitive drug release, and renal clearance Biomaterials 2011 32 20 4604 4608 10.1016/j.biomaterials.2011.02.064 2-s2.0-79955524150 21453965 

  30. 30 Li W. Feng S. Guo Y. Block copolymer for nanomedicine Nanomedicine 2012 7 3 383 392 22385198 

  31. 31 Li W. Li H. Li J. Self-assembled supramolecular nano vesicles for safe and highly efficient gene delivery to solid tumors International Journal of Nanomedicine 2012 7 4661 4677 10.2147/ijn.s34675 2-s2.0-84870322730 22977303 

  32. 32 Li W. Zhao H. Qian W. Chemotherapy for gastric cancer by finely tailoring anti-Her2 anchored dual targeting immunomicelles Biomaterials 2012 33 21 5349 5362 10.1016/j.biomaterials.2012.04.016 2-s2.0-84860916493 22542611 

  33. 33 Ayano E. Karaki M. Ishihara T. Kanazawa H. Okano T. Poly (N-isopropylacrylamide)-PLA and PLA blend nanoparticles for temperature-controllable drug release and intracellular uptake Colloids and Surfaces B: Biointerfaces 2012 99 67 73 10.1016/j.colsurfb.2011.10.003 2-s2.0-84857707300 22088756 

  34. 34 Li W. Zhang L. Zhang G. The finely regulating well-defined functional polymeric nanocarriers for anti-tumor immunotherapy Mini-Reviews in Medicinal Chemistry 2013 13 5 643 652 10.2174/1389557511313050003 2-s2.0-84877834157 23469780 

  35. 35 Li W. Nakayama M. Akimoto J. Okano T. Effect of block compositions of amphiphilic block copolymers on the physicochemical properties of polymeric micelles Polymer 2011 52 17 3783 3790 10.1016/j.polymer.2011.06.026 2-s2.0-79961030148 

섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로